What sectors does EVERSANA INTOUCH focus on?

EVERSANA INTOUCH focuses on Digital Health, Healthtech.

EVERSANA INTOUCH

8 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into EVERSANA INTOUCH

730 people in our graph share verified history with the EVERSANA INTOUCH team — schools, employers, funds. One of them is your warm intro.

Minh Dounlockedknows Brady Walcott · together at SMU Cox School of Business

×2knows the team · via Isenberg School of Management, UMass Amherst

×2knows the team · via DePaul University

×2knows the team · via Occidental College

knows the team · via Cain Brothers & Company, LLC

×2knows the team · via SMU Cox School of Business

✨ Fox Verdict

Investment thesis

EVERSANA INTOUCH serves as a commercial services partner for life sciences organizations seeking to transform their commercialization strategies. The firm operates with AI as its foundational technology platform while leveraging human expertise to create differentiation. Its integrated approach connects digital patient engagement, market access, and commercialization services to deliver measurable outcomes at scale for pharmaceutical companies and life sciences brands.

Invests inDigital Health Healthtech Global

Source: firm website, verified Aug 6, 2026.

Founded

1999

Team · 8 people

from the firm's website

Faruk Capan· Founder, EVERSANA INTOUCH & Chief Innovation Officer, EVERSANA· Pompano Beach, Florida, United Statesin

Founder of EVERSANA INTOUCH (established 1999) and Chief Innovation Officer at EVERSANA. Started his first business at age nine and created MSWatch.com, an online community for people with multiple sclerosis, before founding the company.

Mike Guarino· Chief Executive Officer· New York, New York, United Statesin

Mike Guarino was appointed Chief Executive Officer of EVERSANA INTOUCH, having previously worked across several healthcare marketing organizations. His focus at the company centers on expanding its integrated, data- and AI-driven model for pharma commercialization and marketing.

Ann Cave· President, Full Service Agencies· Boston, Massachusetts, United Statesin

President of Full Service Agencies with expertise in launching first-in-class therapeutics and orphan drug approvals. Named Diagnostic Marketing Association Marketer of the Year and recipient of a Gold Award for Best Corporate Marketing Campaign from MM+M.

Brady Walcott· Chief Growth Officer· New York, New York, United Statesin

Chief Growth Officer with 25+ years in healthcare strategy and business development. Previously held executive positions at AstraZeneca, MEplusYOU, and IOMEDIA, now leading growth strategies across global affiliates in the US, EU, APAC, and LATAM.

Drew McCormick· Chief Operating Officer· New York, New York, United Statesin

Chief Operating Officer overseeing data strategy and operations across commercialization solutions. Has over a decade of experience in healthcare information technology and digital life sciences, with degrees in accounting from University of Texas at Austin.

John Kenny· Chief Strategy Officer· Greater Chicago Areain

Chief Strategy Officer responsible for strategic planning and leveraging marketing science, AI-generated synthetic data, and creativity research. Brings 25+ years of marketing experience globally with award recognition including Cannes Lions Titanium awards.

Raphaela Cristiano-Davis· Chief Agency Procurement Officer· Greater Chicago Areain

Chief Agency Procurement Officer with over 20 years in finance, procurement, and operational excellence in marketing and advertising. Specializes in compensation model optimization, cost reduction, and revenue growth, and serves on the American Association of Advertising Agencies Finance Committee.

Susan Perlbachs· Chief Creative Officer· New York, New York, United Statesin

Chief Creative Officer bringing nearly 20 years of experience in award-winning creative work for major US and global brands. Named one of PharmaVOICE magazine's Top 100 Most Inspiring People in Life Sciences with a background in diplomacy and world affairs.

Frequently asked questions

What sectors does EVERSANA INTOUCH focus on?: EVERSANA INTOUCH focuses on Digital Health, Healthtech.

Images

Similar investors

8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$100K – $50M

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Balderton Capital

Balderton Capital is a European venture capital firm that backs technology startups.

$5M – $50M

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

$5M – $100M